关于更年期激素治疗的最新情况;当前的指示和未回答的问题
Annice Mukherjee1,2, Susan R Davis3,4
1Centre for Intelligent Healthcare, Coventry University, Priory St, Coventry, CV1 5FB, UK.
Clinical endocrinology
|January 29, 2025
概括
更年期激素治疗 (MHT) 为许多女性提供症状缓解和潜在的骨益处. 建议根据个体需求和共享决策量身定制的MHT使用,承认不同人群的数据差距.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 妇女健康 妇女健康
- 证据综合 证据综合
背景情况:
- 更年期激素治疗 (MHT) 是缓解更年期症状的关键治疗选择.
- 了解MHT的有效性和安全性的当前证据基础对于临床实践至关重要.
研究的目的:
- 总结关于临床医生更年期激素治疗 (MHT) 的当前证据.
- 评估MHT的指示,疗效和安全性,强调数据限制.
主要方法:
- 从观察性研究,RCT,元分析和评论中收集的综合证据的系统审查和综合.
- 专注于自然更年期妇女的MHT结果,仔细检查现有数据并确定差距.
主要成果:
- 在不同的人口统计学方面,MHT的影响有很大差异.
- 证据支持MHT缓解症状和潜在的中年骨健康益处.
- 目前的数据显示更年期健康不平等和研究缺口,特别是在代表性不足的群体.
结论:
- 建议针对特定适应症量身定制的MHT使用,通过共享决策来平衡好处和风险.
- 对于许多女性来说,MHT可以提供症状缓解和骨效益.
- 需要进行进一步的研究,以解决当代MHT用户群体中的各种证据差距.
相关概念视频
Menopause
129
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
129
Hormonal Regulation of the Menstrual Cycle
277
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
277
Hormonal Control of the Ovarian Cycle
393
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
393
Internal Receptors
69.3K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
69.3K
Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
Drug Administration and Therapy Phases: Overview
406
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
406


